home / stock / phio / phio news

PHIO News and Press, Phio Pharmaceuticals Corp. From 09/06/23

Stock Information
Company Name: Phio Pharmaceuticals Corp.
Stock Symbol: PHIO
Market: NASDAQ
Website: phiopharma.com
Menu
PHIO PHIO Quote PHIO Short PHIO News PHIO Articles PHIO Message Board
Get PHIO Alerts

News, Short Squeeze, Breakout and More Instantly...
PHIO - Phio CEO to Speak at Wainwright Conference in New York in September

MARLBOROUGH, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to make immune cells more effective in killing tumor cells, today announced that its Presi...
PHIO - Phio Pharmaceuticals Announces Dosing of First Patient in Collaborative Clinical Trial with AgonOx, Inc. and Providence Cancer Institute

MARLBOROUGH, Mass., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to make immune cells more effective in killing tumor cells, today announced that its clini...

PHIO - Phio Pharmaceuticals GAAP EPS of -$1.47

2023-08-10 17:24:21 ET Phio Pharmaceuticals press release ( NASDAQ: PHIO ): Q2 GAAP EPS of -$1.47. At June 30, 2023, the Company had cash of $11.3 million as compared with $11.8 million at December 31, 2022. For further details see: Phio Pharmaceuticals GAAP EPS ...

PHIO - Phio Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update

MARLBOROUGH, Mass., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to make immune cells more effective in killing tumor cells, today reported its financial r...
PHIO - Phio Pharmaceuticals Announces Closing of $4 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules

Phio Pharmaceuticals Announces Closing of $4 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules PR Newswire MARLBOROUGH, Mass. , June 2, 2023 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a cli...

PHIO - Phio Pharmaceuticals slides on equity offering

2023-05-31 10:55:41 ET Phio Pharmaceuticals ( NASDAQ: PHIO ) to sell an aggregate of 233,646 common shares in a registered direct offering at $4.28 per share In a concurrent private placement, the company to also sell an aggregate of 700,935 common shares at $4.28 per share in...

PHIO - Marker, Nano-X top healthcare gainers, Belite, Phio among losers

2023-05-31 10:05:20 ET Gainers: Marker Therapeutics ( MRKR ) +34% . Nano-X Imaging ( NNOX ) +13% . Zai Lab ( ZLAB ) +9% . Invivyd ( IVVD ) +8% . Corbus Pharmaceuticals ( CRBP ) +7% . Losers: Belite Bio ( BLTE ) ...
PHIO - Phio Pharmaceuticals Announces $4 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules

Phio Pharmaceuticals Announces $4 Million Concurrent Registered Direct Offering and Private Placement Priced At-the-Market Under Nasdaq Rules PR Newswire MARLBOROUGH, Mass. , May 31, 2023 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical ...

PHIO - XPEV, PHIO and ENVB among pre-market losers

2023-05-25 08:13:15 ET Biocept ( BIOC ) -41% on pricing $5.0M stock offering . QuantaSing Group ( QSG ) -32% . Digital Turbine ( APPS ) -31% after Q4 earning release . Annexon ( ANNX ) -23% . as geographic atrophy candidate fails in ph...

PHIO - Phio stock rises ~12% as cancer drug trial set for patient enrollment

2023-05-24 09:54:18 ET Phio Pharmaceuticals ( NASDAQ: PHIO ) stock rose ~12% on Wednesday after the company said its clinical development partner AgonOx in collaboration with Providence Cancer Institute completed a site initiation visit and can start patient accrual. The t...
Previous 10 Next 10